ライフサイエンスコーパス: mucinous tumor

1 hotspot driver mutations specifically in the mucinous tumor.

2 e a distinct subset of genes was specific to mucinous tumors.

3 ociation of NKX2-1 with the genes induced in mucinous tumors.

4 between ductal type of intraductal papillary mucinous tumors.

5 ely related to nonmucinous tumors but not to mucinous tumors.

6 l/Met variant of COMT decreases the risk for mucinous tumors.

7 y mucinous ascites and multifocal peritoneal mucinous tumors.

8 cer of all principal histologic types except mucinous tumors.

9 erapy, whereas no association was found with mucinous tumors.

10 Nine neoplasms were mucinous tumors (64.3%), including all neoplasms associa

11 ations for serous tumors, KRAS mutations for mucinous tumors, and beta-catenin and PTEN mutations and

12 tones, localization of intraductal papillary mucinous tumors, and localization and treatment of hemob

13 us tumors is associated with size, and small mucinous tumors are very unlikely to be malignant.

14 Mucinous tumors, both borderline and invasive, were more

15 Intraductal papillary mucinous tumors continue to be commonly encountered and

16 d with an increased risk in endometrioid and mucinous tumors [e.g., testosterone, endometrioid tumors

17 inous tumors and 1.03 (95% CI 0.88-1.21) for mucinous tumors; for each year of oral contraceptive use

18 erefore, we present the first mouse model of mucinous tumor formation from ovarian cells and supporti

19 Mucinous tumors had a much higher SI on the T2-weighted

20 s 67%, 72%, and 67%, respectively, with most mucinous tumors having predominantly high SI and a perip

21 s and some included a heterogeneous group of mucinous tumors, including both benign and malignant app

22 Women with PMP often have mucinous tumors involving both the appendix and the ovar

23 indings strongly support the conclusion that mucinous tumors involving the appendix and ovaries in wo

24 Intraductal papillary-mucinous tumor (IPMT) of the pancreatic ducts is increas

25 creas of patients with intraductal papillary mucinous tumors (IPMT) and to analyze their relation to

26 rofiles in a series of intraductal papillary-mucinous tumors (IPMTs) of the pancreas, which represent

27 ce interval: 1.0, 2.4) but decreased risk of mucinous tumors (IRR = 0.3, 95% confidence interval: 0.1

28 The encompessing term intraductal papillary-mucinous tumors is appropriate.

29 Malignancy within mucinous tumors is associated with size, and small mucin

30 Mucinous tumors (n = 18) were the most common malignant

31 Compared to population control cases, mucinous tumors occurred less frequently in the familial

32 endiceal mucinous adenomas (MAs) and ovarian mucinous tumors of low malignant potential (MLMPs) unass

33 Because mucinous tumors of the appendix similarly express MUC2,

34 iant was not significant overall, it was for mucinous tumors of the ovary, with an adjusted RR of 0.2

35 Intraductal papillary mucinous tumors of the pancreas have a biologic behavior

36 inous tumors and 0.98 (95% CI 0.93-1.04) for mucinous tumors (p = 0.00051 and p = 0.0040, respectivel

37 only 50% and 0% of clear cell carcinomas and mucinous tumors, respectively, were positive.

38 AS mutations in granulosa cell tumors and in mucinous tumors, respectively.

39 an be differentiated with MR imaging because mucinous tumors show high SI on T2-weighted fast SE imag

40 None of the five mucinous tumors showed allelic deletion at any of the 13

41 ordinate variants between paired Brenner and mucinous tumors supports a shared origin or progression.

42 convey greater increased risk for women with mucinous tumors than for women with neoplasms of other h

43 DNA from six Brenner tumors with paired mucinous tumors, two Brenner tumors not associated with

44 demonstrated that a set of genes induced in mucinous tumors was shared with genes induced in a nontu

45 The risk of nonmucinous tumors, but not mucinous tumors, was positively associated with a family

46 Two of 11 intraductal papillary mucinous tumors were positive for telomerase activity, b

47 Nonmucinous but not mucinous tumors were significantly associated with menst

48 DCC is retained in the majority of mucinous tumors, which produce high levels of mucins, an

49 ily involving the ovary from primary ovarian mucinous tumors with peritoneal implants.